Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mod Rheumatol ; 11(3): 242-5, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24383734

RESUMO

Abstract An elderly woman with rheumatoid arthritis and receiving nonsteroidal anti-inflammatory drugs (NSAIDs) treatment was diagnosed with a malignant fibrous histiocytoma in her left knee joint. However, no metastatic lesion caused by the malignant fibrous histiocytoma was found, probably owing to the NSAIDs therapy. Her general condition worsened, and eventually led to renal failure and death from progressive respiratory failure caused by pulmonary effusion. This is the first known report of a malignant fibrous histiocytoma originating in the left knee joint that was complicated by rheumatoid arthritis.

2.
Nihon Rinsho Meneki Gakkai Kaishi ; 22(1): 37-42, 1999 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-11185690

RESUMO

The management of disseminated intravascular coagulation (DIC) in a 22-year-old female patient with antiphospholipid syndrome is reported. Gabexate mesilate was given by continuous drip infusion at 1.5 g/day. No effect was seen, therefore Dalteparin sodium (DS) was administered by continuous drip infusion at 70 U/kg/day. The DIC score improved gradually during the first 4 days to normalization by 10 days. However, convulsive seizure was developed. Computed tomographic scan of brain demonstrated brain abscess at lt-basal ganglia. Continuous drainage was performed while administered continuous drip infusion of DS. Follow-up CT after operation showed reduction of low density area which means brain abscess. Finding in this case suggest that DS may play a role in the management of DIC accompanying intracranial infection.


Assuntos
Síndrome Antifosfolipídica/tratamento farmacológico , Abscesso Encefálico/complicações , Coagulação Intravascular Disseminada/tratamento farmacológico , Fibrinolíticos/uso terapêutico , Heparina de Baixo Peso Molecular/uso terapêutico , Sepse/complicações , Adulto , Síndrome Antifosfolipídica/complicações , Feminino , Humanos
3.
Microbiol Immunol ; 32(1): 115-7, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3287102

RESUMO

Escherichia coli showed the chemotactic response for methamphetamine, a biogenic stimulative amine. The response was qualitatively detected by using a paper disk filter. The quantitative assay showed that E. coli responded to methamphetamine at 10(-5) M or more.


Assuntos
Quimiotaxia , Escherichia coli/metabolismo , Metanfetamina/farmacologia , Relação Dose-Resposta a Droga , Escherichia coli/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...